Linklaters has advised EQT Healthcare Growth on the Luxembourg corporate steps related to the structuring and funding of its acquisition of Europa Biosite, a leading distributor of high-quality life science reagents to academic and biopharma researchers across Europe and North America.
Headquartered in Stockholm, Europa Biosite operates in 17 countries and supports more than 60,000 researchers. The company offers access to over ten million scientific products essential to life sciences research, including antibodies, biochemicals, diagnostic kits and ethically sourced biospecimens.
This acquisition represents the third investment in EQT Healthcare Growth’s strategy to scale profitable healthcare companies with a strong growth outlook.
Rémy Bonneau, Partner at Linklaters, said: “We are delighted to have assisted EQT and the team at EQT Healthcare Growth on the Luxembourg corporate steps enabling the closing of the acquisition of Europa Biosite, the third investment of the fund.”
The Linklaters team was led by Corporate Partner Rémy Bonneau and Corporate Counsel Alain Farana. They were supported by Corporate Associates Sofia Lindqvist and Alexia Hervet, as well as Investment Funds Associate Luis Gabriel Jiménez.
For further information, please contact Véronique Cioli, Head of Marketing Europe, on +352 2608 8226.
About Linklaters
Linklaters LLP is a leading global law firm, supporting clients in achieving their strategies wherever they do business. We use our expertise and resources to help clients pursue opportunities and manage risk across emerging and developed markets around the world. The firm counts more than 2,900 lawyers worldwide, the Luxembourg office counts 121 lawyers and a total staff of more than 170.
